Diazoxide and Nω-nitro-L-arginine counteracted Aβ 1-42-induced cytotoxicity

NeuroReport

Volumn 15, Issue 11, 2004, Pages 1813-1817

  Ma, Guozhao ^a   Chen, Shengdi ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

A 1 42; Apoptosis; Diazoxide; Mitochondrial membrane potential; Reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DIAZOXIDE; N(G) NITROARGININE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GLIOMA CELL; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; DIAZOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITROARGININE; PEPTIDE FRAGMENTS;

EID: 4043109284     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnr.0000135694.89237.3d     Document Type: Article

References (23)

1. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N and Ihara Y. Visualization of A beta 42(43) and Abeta40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994; 13:45-53.
2. Pike C, Burdick D, Walencewicz A, Glabe C and Cotman C. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 1993; 13:1676-1686.
3. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I and Rydel RE. β-amyloid peptides destablize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12:376-389.
4. Behl C, Davis J, Lesley R and Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994; 77:817-827.
5. + channels. Science 1994; 264:276-279.
6. De Silva HA, Aronson JK, Grahame-Smith DG, Jobst KA and Smith AD. Abnormal function of potassium channels in platelets of patients with Alzheimer disease. Lancet 1998; 352:1590-1593.
7. + channels. Life Sci 1996; 59:491-498.
8. Sargent CA, Gover GJ, Antonaccio MJ and McCullough JR. The cardioprotective, vasorelaxant and electro-physiological profile of the large conductance calcium-activated potassium channel opener NS-004. J Pharmacol Exp Ther 1993; 266:1422-1429.
9. + channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity. Brain Res 1996; 706:328-332.
10. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD and Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem 2001; 276:33369-33374.
11. Bastianetto S, Ramassamy C, Poirier J and Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 1999; 66:35-41.
12. Mathur A, Hong Y, Kemp BK, Barrientos AA and Erusalimsky JD. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res 2000; 46:126-138.
13. Tsuchiya M, Suematsu M and Suzuchi H. In vivo visualization of oxygen radical-dependent photo emission. Methods Enzymol 1994; 233:128-140.
14. Saldeen J and Welsh N. Nicotinamide-induced apoptosis in insulin producing cells is associated with cleavage of poly(ADP-ribose) polymerase. Mol Cell Endocrinol 1998; 139:99-107.
15. Reers M, Smith TW and Chen LB. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 1991; 30:4480-4486.
16. Ward MW, Rego AC, Frenguelli BG and Nicholls DG. Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells. J Neurosci 2000; 20:7208-7219.
17. Yamauchi T, Kashii S, Yasuyoshi H, Zhang S, Honda Y and Akaike A. Mitochondrial ATP-sensitive potassium channel: a novel site for neuroprotection. Invest Ophthalmol Vis Sci 2003; 44:2750-2756.
18. + channels: possible mechanism of cardioprotection. Circ Res 1997; 81:1072-1082.
19. Pogrebniak HW, Mathews W and Pass HI. Alteration in macrophage free radical and tumor necrosis factor production by a potassium channel activator. J Surg Res 1992; 52:395-400.
20. Haas J, Storch-Hagenlocher B, Biessmann A and Wildemann B. Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro. Neurosci Lett 2002; 322: 121-125.
21. Akama KT, Albanese C, Pestell RG and Van Eldik LJ. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci USA 1998; 95:5795-5800.
22. Jovanovic DV, Mineau F, Notoya K, Reboul P, Martel-Pelletier J and Pelletier JP. Nitric oxide induced cell death in human osteoarthritic synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation. J Rheumatol 2002; 29:2165-2175.
23. Kindler DD, Thiffault C, Solenski NJ, Dennis J, Kostecki V, Jenkins R et al. Neurotoxic nitric oxide rapidly depolarizes and permeabilizes mitochondria by dynamically opening the mitochondrial transition pore. Mol Cell Neurosci 2003; 23:559-573.